| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 6.2e-05 | 1 |